View in EDS HTML Full Text PDF Full Text

Nuclear PML expression as a prognostic biomarker in localised clear cell renal cell carcinoma.

Saved in:
Bibliographic Details
Title: Nuclear PML expression as a prognostic biomarker in localised clear cell renal cell carcinoma.
Authors: Kosola S; Department of Oncology and Radiotherapy, FICAN West Cancer Centre University of Turku and Turku University Hospital Turku Finland.; Doctoral Programme in Clinical Research (DPCR) University of Turku Turku Finland., Laajala TD; Department of Mathematics and Statistics University of Turku Turku Finland.; Research Program in Systems Oncology, Faculty of Medicine University of Helsinki Helsinki Finland., Payne I; Cancer Research Unit, Institute of Biomedicine and FICAN West Cancer Research Laboratories University of Turku Turku Finland.; iCANDOC Doctoral Programme University of Turku Turku Finland., Kukkula A; Cancer Research Unit, Institute of Biomedicine and FICAN West Cancer Research Laboratories University of Turku Turku Finland.; Turku Doctoral Programme of Molecular Medicine (TuDMM) University of Turku Turku Finland., Luomala L; Department of Urology University of Helsinki and Helsinki University Hospital Helsinki Finland., Mirtti T; Research Program in Systems Oncology, Faculty of Medicine University of Helsinki Helsinki Finland.; Department of Pathology University of Helsinki and Helsinki University Hospital Helsinki Finland.; iCAN-Digital Precision Cancer Medicine Flagship Helsinki Finland.; Finnish Cancer Institute Helsinki Finland., Mattila K; Comprehensive Cancer Center Helsinki University Hospital Helsinki Finland., Vainio P; Department of Pathology Turku University Hospital Turku Finland., Sundvall M; Department of Oncology and Radiotherapy, FICAN West Cancer Centre University of Turku and Turku University Hospital Turku Finland.; Cancer Research Unit, Institute of Biomedicine and FICAN West Cancer Research Laboratories University of Turku Turku Finland., Jaakkola PM; Department of Oncology and Radiotherapy, FICAN West Cancer Centre University of Turku and Turku University Hospital Turku Finland.
Source: BJUI compass [BJUI Compass] 2026 Jul 31; Vol. 7 (8), pp. e70258. Date of Electronic Publication: 2026 Jul 31 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101764975 Publication Model: eCollection Cited Medium: Internet ISSN: 2688-4526 (Electronic) Linking ISSN: 26884526 NLM ISO Abbreviation: BJUI Compass Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42540407
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Nuclear PML expression as a prognostic biomarker in localised clear cell renal cell carcinoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Kosola+S%22">Kosola S</searchLink>; Department of Oncology and Radiotherapy, FICAN West Cancer Centre University of Turku and Turku University Hospital Turku Finland.; Doctoral Programme in Clinical Research (DPCR) University of Turku Turku Finland.<br /><searchLink fieldCode="AU" term="%22Laajala+TD%22">Laajala TD</searchLink>; Department of Mathematics and Statistics University of Turku Turku Finland.; Research Program in Systems Oncology, Faculty of Medicine University of Helsinki Helsinki Finland.<br /><searchLink fieldCode="AU" term="%22Payne+I%22">Payne I</searchLink>; Cancer Research Unit, Institute of Biomedicine and FICAN West Cancer Research Laboratories University of Turku Turku Finland.; iCANDOC Doctoral Programme University of Turku Turku Finland.<br /><searchLink fieldCode="AU" term="%22Kukkula+A%22">Kukkula A</searchLink>; Cancer Research Unit, Institute of Biomedicine and FICAN West Cancer Research Laboratories University of Turku Turku Finland.; Turku Doctoral Programme of Molecular Medicine (TuDMM) University of Turku Turku Finland.<br /><searchLink fieldCode="AU" term="%22Luomala+L%22">Luomala L</searchLink>; Department of Urology University of Helsinki and Helsinki University Hospital Helsinki Finland.<br /><searchLink fieldCode="AU" term="%22Mirtti+T%22">Mirtti T</searchLink>; Research Program in Systems Oncology, Faculty of Medicine University of Helsinki Helsinki Finland.; Department of Pathology University of Helsinki and Helsinki University Hospital Helsinki Finland.; iCAN-Digital Precision Cancer Medicine Flagship Helsinki Finland.; Finnish Cancer Institute Helsinki Finland.<br /><searchLink fieldCode="AU" term="%22Mattila+K%22">Mattila K</searchLink>; Comprehensive Cancer Center Helsinki University Hospital Helsinki Finland.<br /><searchLink fieldCode="AU" term="%22Vainio+P%22">Vainio P</searchLink>; Department of Pathology Turku University Hospital Turku Finland.<br /><searchLink fieldCode="AU" term="%22Sundvall+M%22">Sundvall M</searchLink>; Department of Oncology and Radiotherapy, FICAN West Cancer Centre University of Turku and Turku University Hospital Turku Finland.; Cancer Research Unit, Institute of Biomedicine and FICAN West Cancer Research Laboratories University of Turku Turku Finland.<br /><searchLink fieldCode="AU" term="%22Jaakkola+PM%22">Jaakkola PM</searchLink>; Department of Oncology and Radiotherapy, FICAN West Cancer Centre University of Turku and Turku University Hospital Turku Finland.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101764975%22">BJUI compass</searchLink> [BJUI Compass] 2026 Jul 31; Vol. 7 (8), pp. e70258. <i>Date of Electronic Publication: </i>2026 Jul 31 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22John+Wiley+%26+Sons+Ltd%22">John Wiley & Sons Ltd </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101764975 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2688-4526 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226884526%22">26884526 </searchLink><i>NLM ISO Abbreviation: </i>BJUI Compass <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42540407
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/bco2.70258
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: e70258
    Titles:
      – TitleFull: Nuclear PML expression as a prognostic biomarker in localised clear cell renal cell carcinoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Kosola S
      – PersonEntity:
          Name:
            NameFull: Laajala TD
      – PersonEntity:
          Name:
            NameFull: Payne I
      – PersonEntity:
          Name:
            NameFull: Kukkula A
      – PersonEntity:
          Name:
            NameFull: Luomala L
      – PersonEntity:
          Name:
            NameFull: Mirtti T
      – PersonEntity:
          Name:
            NameFull: Mattila K
      – PersonEntity:
          Name:
            NameFull: Vainio P
      – PersonEntity:
          Name:
            NameFull: Sundvall M
      – PersonEntity:
          Name:
            NameFull: Jaakkola PM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 31
              M: 07
              Text: 2026 Jul 31
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2688-4526
          Numbering:
            – Type: volume
              Value: 7
            – Type: issue
              Value: 8
          Titles:
            – TitleFull: BJUI compass
              Type: main
ResultId 1